CG
DGX icon

Curat Global’s Quest Diagnostics DGX Stock Holding History

Curat Global’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118K Hold
600
– – 0.12% 119
2025
Q4 		$104K Hold
600
– – 0.12% 127
2025
Q3 		$114K Hold
600
– – 0.11% 126
2025
Q2 		$108K Hold
600
– – 0.1% 130
2025
Q1 		$102K Buy
+600
New +$98.6K 0.12% 139

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Curat Global's DGX Position: Q1 2026 in Review

Curat Global held its Quest Diagnostics (DGX) position steady in Q1 2026 at 600 shares worth $118K. The position accounts for 0.12% of the portfolio, ranked #119.

Curat Global first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Curat Global held 600 shares of Quest Diagnostics worth $118K as of Q1 2026.
  • Curat Global left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.12% of Curat Global's portfolio in Q1 2026, its #119 holding.
  • Curat Global first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Curat Global's 13F filing for Q1 2026, filed 21 Apr 2026.